'One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection in non-HIV Population: a randomized controlled trial' - author's response

被引：0
|
作者：
Huang, Hung-Ling [1 ,2 ,3 ,4 ]
Lee, Meng-Rui [5 ,6 ,7 ]
Lee, Chih-Hsin [8 ,9 ]
Wang, Jann-Yuan [6 ,7 ]
机构：
[1] Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ Hosp, Div Pulm & Crit Care Med, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan
[6] Natl Taiwan Univ Hosp, Dept Internal Med, 7 Chung Shan South Rd, Taipei 10002, Taiwan
[7] Natl Taiwan Univ, Coll Med, Sch Med, Taipei, Taiwan
[8] Taipei Med Univ, Wanfang Hosp, Div Pulm Med, Taipei, Taiwan
[9] Taipei Med Univ, Wanfang Hosp, Pulm Res Ctr, Taipei, Taiwan
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2024年 / 30卷 / 11期
关键词：
D O I：
10.1016/j.cmi.2024.08.009
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1482 / 1483
页数：2
相关论文
共 5 条
  • [1] One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection in non-HIV Population: a randomized controlled trial
    Huang, Hung-Ling
    Lee, Meng-Rui
    Lee, Chih-Hsin
    Cheng, Meng-Hsuan
    Lu, Po-Liang
    Sheu, Chau-Chyun
    Wang, Jann-Yuan
    Chong, Inn-Wen
    Yang, Jinn-Moon
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (11) : 1410 - 1417
  • [2] Re: One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection treatment in non-HIV population by Huang et al.
    Xiao, Ke
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (11)
  • [3] One-Month Rifapentine plus Isoniazid (1HP) is a safe regimen for LTBI treatment in non- HIV population: A randomized controlled trial
    Wang, Jann-Yuan
    Huang, Hung-Ling
    Lee, Chih-Hsin
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [4] Completion Rate and Side-Effect Profile of Three-Month Isoniazid and Rifapentine Treatment for Latent Tuberculosis Infection in an Urban County Jail
    Juarez-Reyes, Maria
    Gallivan, Mark
    Chyorny, Alexander
    O'Keeffe, Linda
    Shah, Neha S.
    OPEN FORUM INFECTIOUS DISEASES, 2016, 3 (01):
  • [5] Higher adverse drug reactions but better completion rate of twelve-dose weekly rifapentine plus isoniazid comparing with nine-month daily isoniazid for latent tuberculosis infection among patients under maintenance dialysis
    Lin, Shu-Yung
    Wang, Ping-Huai
    Feng, Jia-Yih
    Shu, Chin-Chung
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
1